500 related articles for article (PubMed ID: 31661524)
1. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
Niriella MA; Kasturiratna A; Beddage T; Ediriweera DS; De Silva ST; Perera KR; Subasinghe CE; Kodisinghe SK; Piyaratna TC; Rishikesawan V; Dassanayaka AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; Janaka de Silva H
PLoS One; 2019; 14(10):e0224474. PubMed ID: 31661524
[TBL] [Abstract][Full Text] [Related]
2. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Li XD; Qiu BH; Su FC; Sun SX
Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
[TBL] [Abstract][Full Text] [Related]
3. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans.
Niriella MA; Pathmeswaran A; De Silva ST; Kasturiratna A; Perera R; Subasinghe CE; Kodisinghe K; Piyaratna C; Rishikesawan V; Dassanayaka AS; De Silva AP; Wickramasinghe R; Takeuchi F; Kato N; de Silva HJ
Liver Int; 2017 Nov; 37(11):1715-1722. PubMed ID: 28544258
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community.
Rajindrajith S; Pathmeswaran A; Jayasinghe C; Kottahachchi D; Kasturiratne A; de Silva ST; Niriella MA; Dassanayake AS; de Silva AP; de Silva HJ
BMC Gastroenterol; 2017 Nov; 17(1):135. PubMed ID: 29187144
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: A prospective, community-cohort study.
Niriella MA; Kasturiratne A; Beddage TU; Withanage SA; Goonatilleke DC; Abeysinghe CP; De Mel RT; Balapitiya TL; De Silva ST; Dassanayake AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; de Silva HJ
Liver Int; 2020 Jan; 40(1):101-106. PubMed ID: 31472085
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prevalence of alcoholic fatty liver disease: a prospective, community-based study among adult Sri Lankans.
Niriella MA; Kasturiratne A; Beddage T; De Silva ST; Dassanayake A; Pathmeswaran A; Wickramasinghe AR; Kato N; De Silva HJ
Ceylon Med J; 2022 Jun; 67(2):45-51. PubMed ID: 37609040
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
[TBL] [Abstract][Full Text] [Related]
9. Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.
Amin RF; El Bendary AS; Ezzat SE; Mohamed WS
Diabetes Metab Syndr; 2019; 13(3):2226-2229. PubMed ID: 31235161
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
[TBL] [Abstract][Full Text] [Related]
11. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
[TBL] [Abstract][Full Text] [Related]
12. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
13. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study.
Wang S; Zhang C; Zhang G; Yuan Z; Liu Y; Ding L; Sun X; Jia H; Xue F
BMJ Open; 2016 Jun; 6(6):e010342. PubMed ID: 27251683
[TBL] [Abstract][Full Text] [Related]
14. The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS).
Mansour-Ghanaei R; Mansour-Ghanaei F; Naghipour M; Joukar F; Atrkar-Roushan Z; Tabatabaii M; Ghorani N
J Med Life; 2018; 11(3):194-202. PubMed ID: 30364682
[No Abstract] [Full Text] [Related]
15. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
16. Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.
Ni L; Yu D; Wu T; Jin F
Medicine (Baltimore); 2021 Feb; 100(6):e24743. PubMed ID: 33578624
[TBL] [Abstract][Full Text] [Related]
17. Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women.
Hong SH; Hwang SY; Kim JA; Lee YB; Roh E; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
Menopause; 2020 Jan; 27(1):88-94. PubMed ID: 31613826
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
Prokopowicz Z; Malecka-Tendera E; Matusik P
Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
[TBL] [Abstract][Full Text] [Related]
19. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
